Pick of Trump loyalist Overton revives questions of FDA independence 

By nominating Heidi Overton to be FDA’s next commissioner, the Trump administration is choosing a loyalist figure who will continue to advance the MAHA agenda put forth by HHS Secretary Robert F. Kennedy Jr. and the broader MAGA political movement.

The choice will raise further questions about FDA’s independence from political and ideological influence. Overton’s expected nomination would follow Marty Makary’s term in the position, one that was marked by conflicts with the administration and controversial regulatory decisions...